Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147818399> ?p ?o ?g. }
- W3147818399 endingPage "493" @default.
- W3147818399 startingPage "483" @default.
- W3147818399 abstract "Rheumatoid arthritis (RA) is a common autoimmune disease characterized by joint inflammation and immune dysfunction. Although various therapeutic approaches have been utilized for the treatment of RA in clinical applications, the low responsiveness of RA patients and undesired systemic toxicity are still unresolved problems. Targeting the resolution pathway of inflammation with pro-resolving mediators would evoke the protective actions of patient for combating the inflammation. Ac2-26, a 25-amino acid peptide derived from Annexin A (a pro-resolving mediator), has shown good efficacy in the treatment of inflammatory disorders. However, the low bioavailability of Ac2-26 peptides hinders their efficacy in vivo. In this paper, we formed PEGylated lipid nanoparticles (LDNPs) by the co-assembly of l-ascorbyl palmitate (L-AP) and N-(carbonyl methoxypolyethylene glycol-2000)-1,2-distearoyl-sn‑glycero-3-phosphoethanolamine (DSPE-PEG2k) to encapsulate and deliver Ac2-26 peptides to the arthritic rats. They showed good stability and biocompatibility. After being intravenously administrated, Ac2-26 peptide-loaded PEGylated lipid nanoparticles (ADNPs) showed the prolonged in vivo circulation time and enhanced accumulation in inflamed sites. In vivo therapeutic evaluations revealed that ADNPs could attenuate synovial inflammation and improve joint pathology. Therefore, the pro-resolving therapeutic strategy using ADNPs is effective in RA treatment." @default.
- W3147818399 created "2021-04-13" @default.
- W3147818399 creator A5003786034 @default.
- W3147818399 creator A5003849971 @default.
- W3147818399 creator A5012379646 @default.
- W3147818399 creator A5015860450 @default.
- W3147818399 creator A5040967667 @default.
- W3147818399 creator A5042282398 @default.
- W3147818399 date "2021-07-01" @default.
- W3147818399 modified "2023-10-17" @default.
- W3147818399 title "Targeting the resolution pathway of inflammation using Ac2–26 peptide-loaded PEGylated lipid nanoparticles for the remission of rheumatoid arthritis" @default.
- W3147818399 cites W1500446363 @default.
- W3147818399 cites W1856034726 @default.
- W3147818399 cites W1970969306 @default.
- W3147818399 cites W1977074396 @default.
- W3147818399 cites W1984554579 @default.
- W3147818399 cites W2010183593 @default.
- W3147818399 cites W2012721880 @default.
- W3147818399 cites W2014462125 @default.
- W3147818399 cites W2041965025 @default.
- W3147818399 cites W2047677831 @default.
- W3147818399 cites W2133496985 @default.
- W3147818399 cites W2133718879 @default.
- W3147818399 cites W2141134562 @default.
- W3147818399 cites W2198808464 @default.
- W3147818399 cites W2278476490 @default.
- W3147818399 cites W2279007355 @default.
- W3147818399 cites W2288963150 @default.
- W3147818399 cites W2293276114 @default.
- W3147818399 cites W2322047794 @default.
- W3147818399 cites W2333427125 @default.
- W3147818399 cites W2397948429 @default.
- W3147818399 cites W2556054532 @default.
- W3147818399 cites W2568405604 @default.
- W3147818399 cites W2591989059 @default.
- W3147818399 cites W2611782291 @default.
- W3147818399 cites W2619345603 @default.
- W3147818399 cites W2623617647 @default.
- W3147818399 cites W2752330924 @default.
- W3147818399 cites W2755630841 @default.
- W3147818399 cites W2791371888 @default.
- W3147818399 cites W2801522264 @default.
- W3147818399 cites W2808296583 @default.
- W3147818399 cites W2885800801 @default.
- W3147818399 cites W2888538308 @default.
- W3147818399 cites W2892314042 @default.
- W3147818399 cites W2915064060 @default.
- W3147818399 cites W2972732188 @default.
- W3147818399 cites W2999338022 @default.
- W3147818399 cites W3006490469 @default.
- W3147818399 cites W3016061954 @default.
- W3147818399 cites W3049700996 @default.
- W3147818399 doi "https://doi.org/10.1016/j.ajps.2021.03.001" @default.
- W3147818399 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8520054" @default.
- W3147818399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34703497" @default.
- W3147818399 hasPublicationYear "2021" @default.
- W3147818399 type Work @default.
- W3147818399 sameAs 3147818399 @default.
- W3147818399 citedByCount "8" @default.
- W3147818399 countsByYear W31478183992021 @default.
- W3147818399 countsByYear W31478183992022 @default.
- W3147818399 countsByYear W31478183992023 @default.
- W3147818399 crossrefType "journal-article" @default.
- W3147818399 hasAuthorship W3147818399A5003786034 @default.
- W3147818399 hasAuthorship W3147818399A5003849971 @default.
- W3147818399 hasAuthorship W3147818399A5012379646 @default.
- W3147818399 hasAuthorship W3147818399A5015860450 @default.
- W3147818399 hasAuthorship W3147818399A5040967667 @default.
- W3147818399 hasAuthorship W3147818399A5042282398 @default.
- W3147818399 hasBestOaLocation W31478183991 @default.
- W3147818399 hasConcept C150903083 @default.
- W3147818399 hasConcept C185592680 @default.
- W3147818399 hasConcept C203014093 @default.
- W3147818399 hasConcept C207001950 @default.
- W3147818399 hasConcept C2776914184 @default.
- W3147818399 hasConcept C2777077863 @default.
- W3147818399 hasConcept C2777575956 @default.
- W3147818399 hasConcept C2779149719 @default.
- W3147818399 hasConcept C553184892 @default.
- W3147818399 hasConcept C68246026 @default.
- W3147818399 hasConcept C71924100 @default.
- W3147818399 hasConcept C86803240 @default.
- W3147818399 hasConcept C88634738 @default.
- W3147818399 hasConcept C98274493 @default.
- W3147818399 hasConceptScore W3147818399C150903083 @default.
- W3147818399 hasConceptScore W3147818399C185592680 @default.
- W3147818399 hasConceptScore W3147818399C203014093 @default.
- W3147818399 hasConceptScore W3147818399C207001950 @default.
- W3147818399 hasConceptScore W3147818399C2776914184 @default.
- W3147818399 hasConceptScore W3147818399C2777077863 @default.
- W3147818399 hasConceptScore W3147818399C2777575956 @default.
- W3147818399 hasConceptScore W3147818399C2779149719 @default.
- W3147818399 hasConceptScore W3147818399C553184892 @default.
- W3147818399 hasConceptScore W3147818399C68246026 @default.
- W3147818399 hasConceptScore W3147818399C71924100 @default.
- W3147818399 hasConceptScore W3147818399C86803240 @default.
- W3147818399 hasConceptScore W3147818399C88634738 @default.
- W3147818399 hasConceptScore W3147818399C98274493 @default.